ArticleJHEP reports : innovation in hepatology2023

SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression.

Martina Mang Leng Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.